Trial Profile
Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Myocardial infarction
- Focus Pharmacokinetics
- Acronyms PINPOINT
- 26 Apr 2017 Status changed from recruiting to completed.
- 18 Nov 2015 New trial record